The impact of amyloid beta burden on white matter dysfunction and associated transcriptomic signatures in cognitively

Ziyun Li1,2, Yuxiao Sun1,2, Ting Li1,2

  • 1State Key Laboratory of Cognitive Neuroscience and Learning Beijing Normal University Beijing China.

Abstract

Insights

Amyloid beta (Aβ) accumulation damages white matter (WM) in cognitively normal individuals before gray matter atrophy occurs in preclinical Alzheimer's disease (AD). This WM damage may involve oligodendrocyte dysfunction and myelination pathways.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Biomarker Discovery

Background:

  • Amyloid beta (Aβ) is a key marker in early Alzheimer's disease (AD).
  • Aβ disrupts white matter (WM) microstructure.
  • Spatial patterns and genetic links of Aβ-related WM changes in cognitively normal individuals are not well understood.

Purpose of the Study:

  • To compare WM microstructure in cognitively normal individuals with and without Aβ.
  • To investigate the relationship between WM fiber tracts and connected brain regions.
  • To explore the underlying gene expression related to Aβ-driven WM changes.

Main Methods:

  • Comparison of WM microstructure between Aβ-positive and Aβ-negative cognitively normal individuals.
  • Analysis of fiber tract connections to cortical and subcortical regions.
  • Investigation of gene expression linked to WM integrity.

Main Results:

  • WM damage was observed in eight fiber tracts in Aβ-positive individuals, preceding atrophy.
  • This damage correlated with cortical Aβ accumulation.
  • Potential links to genes regulating oligodendrocyte function and myelination were identified.

Conclusions:

  • Cortical Aβ-related WM changes precede gray matter atrophy in preclinical AD, serving as potential early biomarkers.
  • Oligodendrocyte dysfunction and myelination pathways may explain Aβ-driven WM vulnerability.
  • These findings suggest potential therapeutic targets for intervention.